Sysmex (6869) Q3 2025 earnings summary

Executive summary

• Net sales, operating profit, and profit attributable to owners reached record highs for the first nine months, with net sales up 12.4%, operating profit up 24.2%, and profit attributable to owners up 23.7% year-over-year.

• Overseas sales accounted for 87.1% of total sales, with notable growth in all regions, especially Asia Pacific (+20.5%) and China (+11.7%).

• Sales increased in all regions, driven by higher reagent sales and growth in emerging markets.

• Sysmex launched innovative products in Japan, including the HISCL TARC Assay Kit and a reagent solution in recycled containers, and was included in the DJSI World for the ninth consecutive year.

• Operating profit growth was supported by SG&A control and yen depreciation.

Financial highlights

• Net sales: ¥366.8B (+12.4% YoY); operating profit: ¥67.3B (+24.2% YoY); profit attributable to owners: ¥42.6B (+23.7% YoY).

• Gross profit increased to ¥198.8B from ¥171.8B YoY; gross margin improved.

• Cost of sales ratio improved to 45.8% from 47.4% YoY; SG&A expenses rose 14.7% YoY; R&D expenses decreased 2.9% YoY.

• Q3 net sales: ¥124.3B (+9.3% YoY); Q3 operating profit: ¥22.8B (+12.0% YoY); Q3 profit attributable to owners: ¥16.6B (+35.3% YoY).

• Basic earnings per share for the nine months was ¥68.35, reflecting a three-for-one stock split.

Outlook and guidance

• Full-year forecast unchanged: net sales ¥510.0B (+10.5% YoY), operating profit ¥90.0B (+14.9% YoY), profit attributable to owners ¥55.0B (+10.8% YoY), and basic EPS ¥88.21.

• No revisions to financial or dividend forecasts; annual dividend forecast is ¥30.00 per share post-split.

• Expect continued sales growth from product portfolio expansion in developed markets and high demand in emerging markets.

• Higher profits anticipated due to improved cost of sales ratio and controlled SG&A and R&D expenses.

• Progress toward full-year targets: net sales 71.9%, operating profit 74.8% as of Q3.